Last update 23 Jan 2025

Aventis Pasteur MSD SNC

Private Company|
France

Overview

Tags

Infectious Diseases
Combination vaccine
Prophylactic vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Combination vaccine1
Prophylactic vaccine1

Related

1
Drugs associated with Aventis Pasteur MSD SNC
Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W-135 Combined(Sanofi)
Target-
Mechanism
Immunostimulants
Active Org.
Aventis Pasteur MSD SNC
Originator Org.
SanofiSanofi
Active Indication
Meningococcal Infections
Inactive Indication
Chickenpox [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date09 Dec 1999
1
Clinical Trials associated with Aventis Pasteur MSD SNC
EUCTR2004-002586-21-DE
/ Not yet recruitingNot Applicable
An open, randomised, comparative, multicentre study of the immunogenicity and safety of M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX® when administered concomitantly by intramuscular (IM) route or subcutaneous (SC) route at two separate injection sites in healthy subjects 12 to 18 months of age - MMR rHA + VARIVAX IM or SC in 12-18 month-old healthy subjects
100 Clinical Results associated with Aventis Pasteur MSD SNC
Login to view more data
0 Patents (Medical) associated with Aventis Pasteur MSD SNC
Login to view more data
100 Deals associated with Aventis Pasteur MSD SNC
Login to view more data
100 Translational Medicine associated with Aventis Pasteur MSD SNC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W-135 Combined(Sanofi)
Meningococcal Infections
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free